To measure or not to measure direct oral anticoagulants before surgery or invasive procedures-Reference-Cited by-同舟云学术

To measure or not to measure direct oral anticoagulants before surgery or invasive procedures

Published:2016-06-13 Issue:7 Volume:14 Page:1325-1327
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Tripodi A.¹

Affiliation:

1. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center; Department of Clinical Sciences and Community Health; Università degli Studi di Milano and IRCCS Cà Granda Maggiore Hospital Foundation; Milan Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.13344/fullpdf

Reference7 articles.

1. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition);Douketis;Chest,2008

2. New oral anticoagulant agents - general features and outcomes in subsets of patients;Schulman;Thromb Haemost,2014

3. Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA);Pengo;Thromb Haemost,2011

4. Effect of standardized perioperative dabigatran interruption on residual anticoagulation effect at the time of surgery or procedure;Douketis;J Thromb Haemost,2016

5. Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis;Baglin;J Thromb Haemost,2013

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study;Blood Advances;2024-04-10

2. LOW LEVELS OF DIRECT ORAL ANTICOAGULANTS AT STEADY STATE IN ATRIAL FIBRILLATION PATIENTS WHO LATER DEVELOP THROMBOTIC COMPLICATIONS; THE PROSPECTIVE MAS (MEASURE AND SEE) STUDY;2023-12-10

3. Comparisons between diluted thrombin time, ecarin chromogenic assays, and UPLC–MS for plasma level dabigatran quantification: Results from DRIVING study;International Journal of Laboratory Hematology;2023-09-14

4. Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective;Neurological Sciences;2023-08-07

5. Current insights into the possible role of laboratory monitoring of effectiveness and safety of direct oral anticoagulants;Rational Pharmacotherapy in Cardiology;2023-07-27